Stoke Therapeutics, Inc.
STOK
42 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 1,461 | $29.99 | $43.8K | 40,702(D) | View → |
| Mar 18, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 6,686 | $31.34 | $209.6K | 40,798(D) | View → |
| Mar 17, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 6,164 | $33.01 | $203.5K | 47,484(D) | View → |
| Mar 18, 2026 | Mar 19 10:00 PM | Thomas LeggettChief Financial Officer | Sale | 2,382 | $31.34 | $74.7K | 10,172(D) | View → |
| Mar 17, 2026 | Mar 19 10:00 PM | Thomas LeggettChief Financial Officer | Sale | 2,196 | $33.01 | $72.5K | 12,554(D) | View → |
| Mar 18, 2026 | Mar 19 9:58 PM | Jason HoittChief Patient Officer | Sale | 1,931 | $31.34 | $60.5K | 10,276(D) | View → |
| Mar 17, 2026 | Mar 19 9:58 PM | Jason HoittChief Patient Officer | Sale | 1,781 | $33.01 | $58.8K | 12,207(D) | View → |
| Mar 18, 2026 | Mar 19 9:57 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Sale | 4,628 | $31.34 | $145.1K | 28,836(D) | View → |
| Mar 17, 2026 | Mar 19 9:57 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Sale | 4,267 | $33.01 | $140.8K | 33,464(D) | View → |
| Mar 19, 2026 | Mar 19 8:19 PM | BARUCH S. TICHO | Proposed Sale | 1,461 | $31.02 | $45.3K | — | View → |
| Mar 13, 2026 | Mar 17 9:23 PM | LEVIN ARTHUR ADirector | Sale | 605 | $36.80 | $22.3K | 4,237(D) | View → |
| Mar 13, 2026 | Mar 13 8:19 PM | ARTHUR A LEVIN | Proposed Sale | 605 | $36.48 | $22.1K | — | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Sale | 4,355 | $40.00 | $174.2K | 31,339(D) | View → |
| Mar 10, 2026 | Mar 12 8:56 PM | Adrian R. KrainerDirector | Sale | 33,243 | $39.74 | $1.3M | 283,302(D) | View → |
| Mar 10, 2026 | Mar 10 8:39 PM | ARTHUR TZIANABOS | Proposed Sale | 90,508 | $38.31 | $3.5M | — | View → |
| Mar 2, 2026 | Mar 4 9:28 PM | Adrian R. KrainerDirector | Sale | 7,229 | $39.66 | $286.7K | 316,545(D) | View → |
| Mar 2, 2026 | Mar 2 9:42 PM | Adrian Krainer | Proposed Sale | 40,472 | $36.41 | $1.5M | — | View → |
| Dec 8, 2025 | Dec 8 9:40 PM | EDWARD M KAYE | Proposed Sale | 13,430 | $30.87 | $414.6K | — | View → |
| Dec 8, 2025 | Dec 8 9:38 PM | JONATHAN ALLAN | Proposed Sale | 3,978 | $30.87 | $122.8K | — | View → |
| Dec 5, 2025 | Dec 5 9:38 PM | EDWARD M KAYE | Proposed Sale | 2,181 | $31.05 | $67.7K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 9:23 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Option Exercise | 25,475 | — | 36,000(D) | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Option Exercise | 3,955 | $8.33 | 118,696(D) | View → |
| Feb 17, 2026 | Feb 19 9:25 PM | Barry TichoCHIEF MEDICAL OFFICER | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:24 PM | Ian F SmithDirector, Chief Executive Officer | Grant/Award | 322,000 | $31.09 | 129,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:22 PM | Thomas LeggettChief Financial Officer | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:21 PM | Jason HoittChief Patient Officer | Grant/Award | 120,000 | $31.09 | 48,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:20 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Grant/Award | 88,000 | $31.09 | 35,000(D) | View → |
← Previous
Page 2 of 2